Top Pharma Companies in India by Market Cap

BSE Sensex 74596.96 262.03 (-0.35%)

Filter

Top Pharma Companies in India as on Sep-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Take Ltd.	Q V PT	238 Small Cap	15.80 (-4.13%)	19.01	7.6	-100.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Gennex Laboratories Ltd.	Q V PT	250 Small Cap	10.35 (0.68%)	12.88	1.1	19.91	45.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Medico Remedies Ltd.	Q V PT	291 Small Cap	33.81 (-0.85%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Ambalal Sarabhai Enterprises Ltd.	Q V PT	310 Small Cap	39.24 (1.50%)	21.85	1.83	4.33	3.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Medicamen Biotech Ltd.	Q V+ PT	448 Small Cap	328.95 (4.63%)	39.38	1.58	5.31	-13.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Fabtech Technologies Ltd.	Q V PT	659 Small Cap	146.95 (-0.61%)	13.5	1.55	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Kilitch Drugs (India) Ltd.	Q V PT	678 Small Cap	213.20 (5.00%)	23.62	2.52	28.00	58.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Wanbury Ltd.	Q V+ PT	780 Small Cap	224.05 (-1.69%)	18.54	11.88	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Gaudium IVF and Women Health Ltd.	Q V PT	845 Small Cap	111.50 (-0.67%)	33.4	5.3	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Anuh Pharma Ltd.	Q V PT	936 Small Cap	95.19 (1.82%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	One Global Service Provider Ltd.	Q V+ PT	1,056 Small Cap	550 (2.34%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Laxmi Dental Ltd.	Q V PT	1,087 Small Cap	193.60 (-0.56%)	34.69	4.24	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Bajaj Healthcare Ltd.	Q V PT	1,108 Small Cap	336.55 (0.16%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Themis Medicare Ltd.	Q V PT	1,149 Small Cap	122.40 (-1.33%)	28.58	2.94	15.00	3.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Sigachi Industries Ltd.	Q V PT	1,130 Small Cap	31.17 (0.16%)	46.9	2.24	28.55	16.06	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	3B Blackbio Dx Ltd.	Q V PT	1,139 Small Cap	1,386.40 (-1.51%)	21.76	4.31	27.29	40.23	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Lincoln Pharmaceuticals Ltd.	Q V PT	1,215 Small Cap	597.85 (-1.30%)	12.58	1.53	10.03	10.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	GPT Healthcare Ltd.	Q V PT	1,361 Small Cap	163.05 (-1.15%)	28.64	4.8	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Kopran Ltd.	Q V+ PT	1,342 Small Cap	272.35 (-3.78%)	54.75	2.55	6.74	-8.11	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Fermenta Biotech Ltd.	Q V PT	1,400 Small Cap	473.50 (-0.17%)	23.08	3.38	6.85	5.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Anlon Healthcare Ltd.	Q V+ PT	1,219 Small Cap	29.04 (10.00%)	49.21	4.81	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Amrutanjan Health Care Ltd.	Q V+ PT	1,427 Small Cap	500.60 (1.04%)	26.54	3.82	8.59	1.17	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Gujarat Kidney And Super Speciality Ltd.	Q V PT	1,432 Small Cap	176 (-3.90%)	91.19	5.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Shalby Ltd.	Q V+ PT	1,489 Small Cap	139.50 (0.69%)	38.07	1.47	21.51	-5.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,504 Small Cap	226.65 (-0.18%)	N/A	N/A	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	NGL Fine-Chem Ltd.	Q V PT	1,716 Small Cap	2,717.90 (-0.46%)	29.49	4.85	14.19	-3.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Krsnaa Diagnostics Ltd.	Q V PT	1,757 Small Cap	571.90 (3.01%)	18.48	1.82	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Tarsons Products Ltd.	Q V PT	1,631 Small Cap	332.30 (-2.26%)	163.05	2.86	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Suraksha Diagnostic Ltd.	Q V PT	1,750 Small Cap	356.75 (2.03%)	50.87	7.1	17.26	-44.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Hester Biosciences Ltd.	Q V PT	1,861 Small Cap	2,190.75 (0.20%)	13.66	4.09	9.19	6.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anlon Healthcare	29.04	10%
Ind-Swift Labs.	408.45	7.05%
Shukra Pharmaceut.	58.70	6.26%
Aarti Pharmalabs	890.25	5.17%
Kilitch Drugs(India)	213.20	5%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Take	15.80	-4.13%
Guj. Kidney & Super	176	-3.90%
Kopran	272.35	-3.78%
Acutaas Chemicals	3,297.10	-3.66%
Kwality Pharma	3,702.80	-3.50%

News about Top Pharma Companies in India

Sep, 2026

Anlon Healthcare incorporates subsidiary in Nigeria

This subsidiary will provide access to 16 Western African Countries via its local entity

Sep, 2026

One Global Service Provider informs about corrigendum to AGM notice

In continuation of its intimation dated 5th September, 2026 regarding the Notice convening the 34th Annual General Meeting (‘AGM’) of the Company dated 3rd September, 2026 (‘AGM Notice’), scheduled to be held on Tuesday, 29th September, 2026 at 02:00 PM IST, One Global Service Provider has informed that a Corrigendum to the AGM Notice (‘Corrigendum’) is being sent today, Monday, 21st September, 2026, through email to the Members to whom the AGM Notice has been dispatched. The Corrigendum provides certain clarifications, modifications, and updates to the resolution and explanatory statement of Item No. 10 of the AGM Notice. A copy of the detailed Corrigendum is enclosed. The Corrigendum to the AGM Notice shall form an integral part of the AGM Notice, the AGM Notice shall always be read in conjunction with this Corrigendum. All other contents of the AGM Notice, save and except as modified or supplemented by Corrigendum, shall remain unchanged. The Corrigendum is also available on the website of the Company at www.1gsp.in and on the website of National Securities Depository Services at www.evoting.nsdl.com. The e-voting period commences on Friday, 25th September, 2026 (09.00 AM IST) and ends on Monday, 28th September, 2026 (05.00 PM IST).

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Anlon Healthcare informs about incorporation of subsidiary

Pursuant to regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (‘SEBI Master Circular’), Anlon Healthcare has informed that ‘ANLON HEALTHCARE NIGERIA’ having Registration Number ‘9874492’ has been incorporated as a subsidiary of the Company, with effect from September 20, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure - A.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics has informed regarding the voting results as the outcome of the postal ballot dated September 17, 2026.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

With reference to its letter no. KDL/SE/032/2026-27 dated August 18, 2026, Krsnaa Diagnostics has informed that it enclosed the Postal Ballot Notice dated August 13, 2026 (‘Notice’) for seeking approval of the shareholders of the Company on special resolution: Approval for Issuance of up to 16,21,000 Warrants Convertible into Equity Shares of Face Value Rs.5/- each on a Preferential Basis to the Promoter and Promoter Group of the Company. Pursuant to Sections 108, 110 and other applicable provisions, if any, of the Companies Act, 2013 (‘the Act’) read with the Companies (Management and Administration) Rules, 2014, guidelines prescribed by the Ministry of Corporate Affairs through various Circular(s) and the Listing Regulations, as amended from time to time, the Postal Ballot was conducted through remote e-voting process. The remote e-voting process concluded on Thursday, September 17, 2026, at 17:00 Hrs. (IST), post which Dinesh Shivnarayan Birla (Membership No.: FCS-7658, COP: 13029), Practicing Company Secretary and Proprietor of Dinesh Birla & Associates, Company Secretaries, Scrutinizer submitted the Report on the Postal Ballot voting results on September 18, 2026. Based on the Scrutinizer’s Report, the company has informed that the Special Resolution mentioned in the Postal Ballot Notice dated August 13, 2026 has been passed by the Members of the Company with requisite majority on September 17, 2026, i.e., the last date of remote e-voting. In connection with the above, it has enclosed the following: a. Voting results pursuant to Regulation 44(3) of the Listing Regulations and Section 108 of the Act read with the Companies (Management and Administration) Rules, 2014; and b. Scrutinizer's Report dated September 18, 2026 on remote e-voting.

The above information is a part of company’s filings submitted to BSE.

Sep, 2026

Fabtech Technologies surges on bagging Rs 21 crore turnkey project

The order marks the company’s entry into this CIS market and expands the company’s international execution footprint into a technically demanding geography

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Take Ltd.	238 Crore
2	Gennex Laboratories Ltd.	250 Crore
3	Medico Remedies Ltd.	291 Crore
4	Ambalal Sarabhai Enterprises Ltd.	310 Crore
5	Medicamen Biotech Ltd.	448 Crore
6	Fabtech Technologies Ltd.	659 Crore
7	Kilitch Drugs (India) Ltd.	678 Crore
8	Wanbury Ltd.	780 Crore
9	Gaudium IVF and Women Health Ltd.	845 Crore
10	Anuh Pharma Ltd.	936 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	27,159	57,954	35.89	11.20	24.65	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,954	1,82,738	83.79	20.36	38.34	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	27.89
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,018	1,05,645	117
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	76.91
Aurobindo Pharma Ltd. (M)	Very Good	1,695	99,828	53.55
Divis Laboratories Ltd. (L)	Very Good	9,370	2,48,664	52.16
Gland Pharma Ltd. (M)	Very Good	2,915	48,875	45.50
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	23.61
Mankind Pharma Ltd. (M)	Very Good	2,463	95,744	46.87	5.69	24.40	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,532	44,562	39.27	9.17	26.53	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,169	1,15,012	25.48	4.27	14.28	13.52
Gland Pharma Ltd. (M)	Very Good	2,915	48,875	43.30	4.60	22.09	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,606	34,003	94.00	13.32	48.48	39.96
Lupin Ltd. (M)	Somewhat Good	2,124	98,070	17.74	4.12	9.82	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,461	67,169	37.36	6.13	12.46	22.19
Abbott India Ltd. (M)	Very Good	27,159	57,954	35.89	11.20	24.65	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,211	97,749	30.34	2.56	15.56	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Anlon Healthcare incorporates subsidiary in Nigeria

One Global Service Provider informs about corrigendum to AGM notice

Anlon Healthcare informs about incorporation of subsidiary

Krsnaa Diagnostics informs about updates

Krsnaa Diagnostics informs about voting results of postal ballot and scrutinizer report

Fabtech Technologies surges on bagging Rs 21 crore turnkey project

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?